(Q39729189)

14 September 2017

1 reference

title

Current status of plasmapheresis in toxicology (English)

1 reference

14 September 2017

Jones JS

1

1 reference

14 September 2017

Dougherty J

series ordinal

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 April 1986

1 reference

Annals of Emergency Medicine

14 September 2017

published in

1 reference

14 September 2017

volume

15

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

474-482

1 reference

Poisoning in children—a statistical study of 1,057 cases

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Applications and limitations of hemapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

William Cobbett, Benjamin Rush, and the death of General Washington.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Treatment of Waldenstrom's macroglobulinemia by plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Therapeutic Plasma Exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Where now for therapeutic apheresis?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasmapheresis and immunosuppressive drug therapy in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

A comparison of centrifugal and membrane-based apheresis formats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Membrane plasmapheresis and the developing technology of plasma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasmapheresis therapy of immunologic disease. Report of nine cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Pharmacokinetics in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasma exchange for mushroom poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

The early removal of amatoxins in the treatment of amanita phalloides poisoning (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasmapheresis for paraquat poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasmapheresis for paraquat poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasmapheresis in the treatment of dialysis encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

1 reference

7 January 2021

Thyroid Storm Treatment With Blood Exchange and Plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Glutethimide poisoning. A metabolite contributes to morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Propranolol Plasma Concentrations and Plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Phenytoin removal by plasmapheresis in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Removal of Tobramycin During Plasma Exchange Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Massive extracorporeal blood clotting during discontinuous flow leukapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasma antithrombin III and plasminogen levels in chronic plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasmapheresis in refractory generalized myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Stroke and Gangrene: Complications of Therapeutic Plasma Exchange Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Therapeutic plasmapheresis. Current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Complications of therapeutic apheresis, including a fatal case with pulmonary vascular occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Mortality in therapeutic haemapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Issues in therapeutic apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Plasmapheresis: a pediatric perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Acute barbiturate intoxication. Concepts of management.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Resin Hemoperfusion for Treatment of Ethchlorvynol Overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Treatment of severe pre-eclampsia by plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Successful Treatment of Fulminating Complications Associated with Extensive Rhabdomyolysis by Plasma Exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

Control of life-threatening bleeding by combined plasmapheresis and immunosuppressive treatment in a haemophiliac with inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2886%2980192-5

7 January 2021

10.1016/S0196-0644(86)80192-5

Identifiers

DOI

1 reference

14 September 2017

1 reference